These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7509318)

  • 1. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
    Alonso de Velasco E; Verheul AF; van Steijn AM; Dekker HA; Feldman RG; Fernández IM; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H
    Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
    Jansen WT; Hogenboom S; Thijssen MJ; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H; Verheul AF
    Infect Immun; 2001 Feb; 69(2):787-93. PubMed ID: 11159969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.
    Alonso de Velasco E; Verheul AF; Veeneman GH; Gomes LJ; van Boom JH; Verhoef J; Snippe H
    Vaccine; 1993 Nov; 11(14):1429-36. PubMed ID: 8310762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M; Eskola J; Ahman H; Käyhty H
    J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-rhamnose is often an important part of immunodominant epitope for pneumococcal serotype 23F polysaccharide antibodies in human sera immunized with PPV23.
    Park S; Nahm MH
    PLoS One; 2013; 8(12):e83810. PubMed ID: 24391831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate Specificity and Isotypes of Monoclonal and Polyclonal Antibodies to Conjugated Tetrasaccharide, a Synthetic Analogue of Repeating Unit of Capsular Polysaccharide of Streptococcus Pneumoniae Serotype 14.
    Kurbatova ЕА; Yakovleva IV; Akhmatova EА; Sukhova ЕV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
    Bull Exp Biol Med; 2019 Feb; 166(4):477-480. PubMed ID: 30788740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to
    Kurbatova EA; Akhmatova NK; Zaytsev AE; Akhmatova EA; Egorova NB; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
    Front Immunol; 2020; 11():578019. PubMed ID: 33343566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
    Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
    J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.
    Theilacker C; Coleman FT; Mueschenborn S; Llosa N; Grout M; Pier GB
    Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Rodewald AK; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1993 Nov; 61(11):4760-6. PubMed ID: 8406875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.
    Sorensen RU; Leiva LE; Giangrosso PA; Butler B; Javier FC; Sacerdote DM; Bradford N; Moore C
    Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.
    Safari D; Dekker HA; Joosten JA; Michalik D; de Souza AC; Adamo R; Lahmann M; Sundgren A; Oscarson S; Kamerling JP; Snippe H
    Infect Immun; 2008 Oct; 76(10):4615-23. PubMed ID: 18678667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.
    Soininen A; Seppälä I; Nieminen T; Eskola J; Käyhty H
    Vaccine; 1999 Apr; 17(15-16):1889-97. PubMed ID: 10217586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.
    Ahman H; Käyhty H; Tamminen P; Vuorela A; Malinoski F; Eskola J
    Pediatr Infect Dis J; 1996 Feb; 15(2):134-9. PubMed ID: 8822286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
    Chu RS; McCool T; Greenspan NS; Schreiber JR; Harding CV
    Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity.
    McCool TL; Harding CV; Greenspan NS; Schreiber JR
    Infect Immun; 1999 Sep; 67(9):4862-9. PubMed ID: 10456942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.
    Anttila M; Eskola J; Ahman H; Käyhty H
    Vaccine; 1999 Apr; 17(15-16):1970-7. PubMed ID: 10217596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
    Snippe H; van Houte AJ; van Dam JE; De Reuver MJ; Jansze M; Willers JM
    Infect Immun; 1983 Jun; 40(3):856-61. PubMed ID: 6852923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.
    Lefeber DJ; Benaissa-Trouw B; Vliegenthart JF; Kamerling JP; Jansen WT; Kraaijeveld K; Snippe H
    Infect Immun; 2003 Dec; 71(12):6915-20. PubMed ID: 14638780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
    Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.